Old ingredient, new science: EPA and DHA omega-3s and emerging health outcomes

The long-chain omega-3s eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are some of the most well-studied nutrients across a multitude of health effects. Yet comparing studies with diverse study designs, dosages and populations is challenging, making understanding broad-scale benefits difficult. What’s going on beyond heart and brain health? Results from a one-of-a-kind clinical study database that catalogues all human clinical trials on EPA and DHA will be shared, with unique insights into the current knowledge and emerging research areas in the field of nutrition and health.

source